Evidence map›Paper›PMID 38126910›Full record

ArticleCancer immunology research2024

A Metabolic Axis of Immune Intractability.

Dominique C Hinshaw, Meet Patel, Lalita A Shevde

Open access · bronzeAbstract read
In one paragraph

Article in Cancer immunology research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 68% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 0 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Dominique C HinshawDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0002-2052-9484
Meet PatelDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0002-9962-0087
Lalita A Shevde *Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0002-1520-1476
University of Alabama at Birmingham · US

Funding

Role of O-GlcNAc-ylation on tumor progressionR01CA262160 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Lalita A. Shevde · 2022 to 2026
$1.5M
NCI NIH HHS R01 CA262160
6 · The paper itself

Abstract

Immune cells in the tumor niche robustly influence disease progression. Remarkably, in cancer, developmental pathways are reenacted. Many parallels between immune regulation of embryonic development and immune regulation of tumor progression can be drawn, with evidence clearly supporting an immune-suppressive microenvironment in both situations. In these ecosystems, metabolic and bioenergetic circuits guide and regulate immune cell differentiation, plasticity, and functional properties of suppressive and inflammatory immune subsets. As such, there is an emerging pattern of intersection across the dynamic process of ontogeny and the ever-evolving tumor neighborhood. In this article, we focus on the convergence of immune programming during ontogeny and in the tumor microenvironment. Exemplifying dysregulation of Hedgehog (Hh) activity, a key player during ontogeny, we highlight a critical convergence of these fields and the metabolic axis of the nutrient sensing hexosamine biosynthetic pathway (HBP) that integrates glucose, glutamine, amino acids, acetyl CoA, and uridine-5'-triphosphate (UTP), culminating in the synthesis of UDP-GlcNAc, a metabolite that functions as a metabolic and bioenergetic sensor. We discuss an emerging pattern of immune regulation, orchestrated by O-GlcNAcylation of key transcriptional regulators, spurring suppressive activity of dysfunctional immune cells in the tumor microenvironment.

Indexed as

Hedgehog ProteinsNeoplasmsEcosystemGlycosylationHumansProtein Processing, Post-TranslationalTumor MicroenvironmentHedgehog Proteins

Identifiers

PMID38126910
PMCPMC10936744
OpenAlexW4388866128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.